Medicine
Zypitamag 2 mg tablet
Zypitamag 2 mg tablet is a prescription medicine containing Pitavastatin for oral use, marketed by Medicure International, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F). Protect from moisture and light.
Key facts
- Active ingredient (INN)
- Pitavastatin
- Brand
- Zypitamag
- Strength
- 2 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 90 tablets, 500 tablets, 1000 tablets and 6 more
- Marketing authorisation holder
- Medicure International
- Manufacturers
- Medicure InternationalZydus LifesciencesIndia
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F). Protect from moisture and light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C10AA08 Pitavastatin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 9 March 2018
- Identifiers
- RxCUI 2001262, 2001264, 2001266 +1DailyMed set ID c8c50e03-5cb8-43f4-bdef-8edd12f1945f, e9f0fe3a-0462-4c24-8f22-3c89afe8fceaNDC 25208-201, 70771-1117Application NDA208379
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 90 tablet, film coated in 1 bottle | 25208-201-09 | Medicure International | 9 March 2018 |
| 500 tablet, film coated in 1 bottle | 25208-201-15 | Medicure International | 9 March 2018 |
| 1000 tablet, film coated in 1 bottle | 70771-1117-0 | Zydus LifesciencesIndia | 9 March 2018 |
| 100 tablet, film coated in 1 bottle | 70771-1117-1 | Zydus LifesciencesIndia | 9 March 2018 |
| 30 tablet, film coated in 1 bottle | 70771-1117-3 | Zydus LifesciencesIndia | 9 March 2018 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 70771-1117-4 | Zydus LifesciencesIndia | 9 March 2018 |
| 500 tablet, film coated in 1 bottle | 70771-1117-5 | Zydus LifesciencesIndia | 9 March 2018 |
| 1 blister pack in 1 carton / 7 tablet, film coated in 1 blister pack | 70771-1117-7 | Zydus LifesciencesIndia | 9 March 2018 |
| 90 tablet, film coated in 1 bottle | 70771-1117-9 | Zydus LifesciencesIndia | 9 March 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 3 August 2009 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Pitavastatin 2 mg tablet.
Other strengths and forms of Pitavastatin
Clinical summary
Pitavastatin is an HMG-CoA reductase inhibitor indicated as an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in adults with primary hyperlipidemia. It is available as tablets for oral use. MedsAcross supplies Pitavastatin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PitavastatinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Livalo prescribing information (Kowa Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Zypitamag 2 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.